268 related articles for article (PubMed ID: 31829284)
1. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
Fifield BA; Qemo I; Kirou E; Cardiff RD; Porter LA
Breast Cancer Res; 2019 Dec; 21(1):140. PubMed ID: 31829284
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation.
Fifield BA; Talia J; Stoyanovich C; Elliott MJ; Bakht MK; Basilious A; Samsoondar JP; Curtis M; Stringer KF; Porter LA
Carcinogenesis; 2020 Jul; 41(6):850-862. PubMed ID: 31574533
[TBL] [Abstract][Full Text] [Related]
3. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis.
McAndrew CW; Gastwirt RF; Donoghue DJ
Cell Cycle; 2009 Jan; 8(1):66-75. PubMed ID: 19106603
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments.
Ferraiuolo RM; Fifield BA; Hamm C; Porter LA
Breast Cancer Res Treat; 2022 Nov; 196(1):17-30. PubMed ID: 36029387
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
Al Sorkhy M; Ferraiuolo RM; Jalili E; Malysa A; Fratiloiu AR; Sloane BF; Porter LA
BMC Cancer; 2012 Jan; 12():45. PubMed ID: 22280365
[TBL] [Abstract][Full Text] [Related]
6. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S
Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
8. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
[TBL] [Abstract][Full Text] [Related]
10. Spy1 expression prevents normal cellular responses to DNA damage: inhibition of apoptosis and checkpoint activation.
Gastwirt RF; Slavin DA; McAndrew CW; Donoghue DJ
J Biol Chem; 2006 Nov; 281(46):35425-35. PubMed ID: 16951407
[TBL] [Abstract][Full Text] [Related]
11. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
12. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
14. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis.
Welz L; Kakavand N; Hang X; Laue G; Ito G; Silva MG; Plattner C; Mishra N; Tengen F; Ogris C; Jesinghaus M; Wottawa F; Arnold P; Kaikkonen L; Stengel S; Tran F; Das S; Kaser A; Trajanoski Z; Blumberg R; Roecken C; Saur D; Tschurtschenthaler M; Schreiber S; Rosenstiel P; Aden K
Gastroenterology; 2022 Jan; 162(1):223-237.e11. PubMed ID: 34599932
[TBL] [Abstract][Full Text] [Related]
15. The DNA resection protein CtIP promotes mammary tumorigenesis.
Reczek CR; Shakya R; Miteva Y; Szabolcs M; Ludwig T; Baer R
Oncotarget; 2016 May; 7(22):32172-83. PubMed ID: 27058754
[TBL] [Abstract][Full Text] [Related]
16. Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage.
Wang XD; Zhu MW; Shan D; Wang SY; Yin X; Yang YQ; Wang TH; Zhang CT; Wang Y; Liang WW; Zhang J; Jiang HZ; Dong GT; Jiang HQ; Qi Y; Feng HL
DNA Repair (Amst); 2019 Feb; 74():51-62. PubMed ID: 30630676
[TBL] [Abstract][Full Text] [Related]
17. p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
Kan CE; Patton JT; Stark GR; Jackson MW
Cancer Res; 2007 Oct; 67(20):9862-8. PubMed ID: 17942917
[TBL] [Abstract][Full Text] [Related]
18. Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.
Bado I; Nikolos F; Rajapaksa G; Wu W; Castaneda J; Krishnamurthy S; Webb P; Gustafsson JÅ; Thomas C
Breast Cancer Res; 2017 Jul; 19(1):79. PubMed ID: 28673316
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
Cui XS; Donehower LA
Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
[TBL] [Abstract][Full Text] [Related]
20. Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53.
Ghaleb A; Yallowitz A; Marchenko N
Commun Biol; 2019; 2():436. PubMed ID: 31799437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
